- ►diabetesjournals.org RS Rosenson, DA Wolff, AL Huskin, IB Helenowski, … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—Fenofibrate treatment lowered fasting triglycerides (−46.1%, P < 0.0001) and
postprandial (area under the curve) triglycerides (−45.4%, P < 0.0001) due to significant
reductions in postprandial levels ... Cited by 26 - Related articles - BL Direct - All 8 versions
RS Rosenson, AL Huskin, DA Wolff, IB Helenowski, AW … - Atherosclerosis, 2008 - Elsevier Fenofibrate treatment reduced concentrations of monohydroxy fatty acids (OH-FA) by 15.5% (p =
0.001), lipopolysaccharide activated monocyte chemotactic protein-1 (MCP-1/CCL2) production in
fasting blood samples by 3.4% (p = ... Cited by 9 - Related articles - All 22 versions
MS Helenowski, AW Rademaker, RS Rosenson - Ann Arbor - Am Diabetes Assoc Received for publication 17 January 2007 and accepted in revised form 26 April 2007. ... Additional
information for this article can be viewed in an online appendix at http://care.diabetesjournals.org
. ... Robert S. Rosenson, MD, ... Related articles - All 2 versions
NI UCGUN, Z YILDIRIM, N KILIC, E … - ANNALS-NEW YORK …, 2007 - interscience.wiley.com Abstract : To evaluate the relationship between serum lipid levels and exudative diabetic
maculopathy in patients with nonproliferative diabetic retinopathy, 27 patients with exudative
diabetic macular edema were ... Cited by 13 - Related articles - BL Direct - All 5 versions
EY Chew, WT Ambrosius, LT Howard, CM Greven, … - The American Journal of …, 2007 - Elsevier Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus. The Action to
Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE), a prospective study of a subset of
patients in the randomized ... Cited by 10 - Related articles - All 2 versions
PM Dodson - Practical Diabetes International, 2008 - interscience.wiley.com While laser treatment is regarded as the standard therapy, intensive medical management of glycaemia
and hypertension is a priority to reduce the risk of diabetic retinopathy. Recent data have prompted
a re-evaluation of the role of ... Cited by 3 - Related articles - BL Direct
R Simó, C Hernández - The Lancet, 2007 - Elsevier The investigators' aim in this latest FIELD report was to assess whether long-term lipid-lowering
therapy with fenofibrate could reduce retinopathy progression in a large sample of patients (nearly
9800) with type 2 diabetes ... Cited by 7 - Related articles - All 16 versions
HT May, JL Anderson, RR Pearson, JR Jensen, BD … - The American Journal of …, 2008 - Elsevier Diabetes mellitus is a strong risk factor for atherosclerosis and is often characterized by
dyslipidemia. Besides acting on traditional lipids, statins and fibrates may also exert beneficial
effects on various pro- and ... Cited by 14 - Related articles - BL Direct - All 4 versions
KE Ryan, DR McCance, L Powell, R McMahon, ER … - Atherosclerosis, 2007 - Elsevier Insulin sensitivity improved with pioglitazone treatment (p = 0.001) and, in keeping with this,
adiponectin increased by 85.2% (p < 0.001). Pro-inflammatory cytokine levels (TNFα, IL-6 and
IL-1β) fell with both treatments ... Cited by 24 - Related articles - All 18 versions
RS ROSENSON - Current atherosclerosis reports, 2006 - cat.inist.fr Field of confusion: Future prospects for fibrate therapy in cardiovascular disease. Robert S ROSENSON
Current atherosclerosis reports 8:33, 219-222, Current Science, 2006.
Cited by 6 - Related articles - All 2 versions
